Williams Jones Wealth Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-23,758
Closed -$2.69M 546
2024
Q2
$2.69M Buy
23,758
+170
+0.7% +$21.5K 0.03% 172
2024
Q1
$3.27M Buy
23,588
+2,350
+11% +$295K 0.04% 153
2023
Q4
$2.64M Sell
21,238
-371
-2% -$37.9K 0.04% 168
2023
Q3
$2.02M Buy
21,609
+5,044
+30% +$569K 0.03% 194
2023
Q2
$2.13M Buy
16,565
+2,110
+15% +$255K 0.03% 192
2023
Q1
$1.68M Sell
14,455
-1,835
-11% -$205K 0.03% 222
2022
Q4
$1.84M Sell
16,290
-57
-0.3% -$6.26K 0.03% 207
2022
Q3
$1.32M Sell
16,347
-1,014
-6% -$85.9K 0.02% 240
2022
Q2
$1.29M Sell
17,361
-26,963
-61% -$2.46M 0.02% 250
2022
Q1
$5.67M Sell
44,324
-9,472
-18% -$1.04M 0.08% 137
2021
Q4
$7.22M Buy
53,796
+20,872
+63% +$3M 0.09% 120
2021
Q3
$4.5M Buy
+32,924
New +$4.15M 0.06% 145

Other funds holding DXCM

Williams Jones Wealth Management's DXCM Position: Q3 2024 in Review

Williams Jones Wealth Management sold out of DexCom (DXCM) in Q3 2024, closing a stake of 23,758 shares — an estimated $2.69M sold.

Williams Jones Wealth Management first reported a position in DXCM in Q3 2021 and held it in 12 quarters. The position peaked at $7.22M in Q4 2021. 890 funds tracked by Wall St. Rank hold DXCM as of Q3 2024.

  • Williams Jones Wealth Management reported no remaining DexCom position as of Q3 2024 after selling out during the quarter.
  • Williams Jones Wealth Management sold 23,758 DexCom shares in Q3 2024, an estimated $2.69M.
  • Williams Jones Wealth Management first reported a position in DexCom in Q3 2021 and held it in 12 quarters.
  • Williams Jones Wealth Management's DexCom position peaked at $7.22M in Q4 2021.
  • 890 funds tracked by Wall St. Rank held DexCom as of Q3 2024.

Based on Williams Jones Wealth Management's 13F filing for Q3 2024, filed 14 Nov 2024.